The global separation systems for commercial biotechnology market size reached USD 28.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 44.7 Billion by 2033, exhibiting a growth rate (CAGR) of 4.98% during 2025-2033.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 28.2 Billion |
Market Forecast in 2033
|
USD 44.7 Billion |
Market Growth Rate 2025-2033 | 4.98% |
The separation systems for commercial biotechnology refer to the solutions used for the purification and separation of biological products from complex mixtures and solutions, including biochemicals, diagnostic reagents and biopharmaceuticals. The separation is based on the electrostatic charge, density, shape, polarity, solubility, diffusivity and volatility of the product. It involves the use of various equipment and devices, such as chromatographs, membranes, filters, centrifuges, biochips and microarrays. These solutions offer improved resin productivity, higher recovery and minimal waste generation and wash water usage. As a result, separation systems find extensive applications across various industries, including pharmaceutical, food and beverage, cosmetic and agriculture.
Significant growth in the pharmaceutical industry across the globe is one of the key factors creating a positive outlook for the market. With the increasing prevalence of chronic medical ailments, there is a rising demand for personalized drugs, biopharmaceuticals and cell-based therapies, which is impacting the demand for separation systems for commercial biotechnology. Moreover, the widespread adoption of magnetic separators for the commercial production of plastics and chemicals is providing a thrust to the market growth. Additionally, various technological advancements, such as the development of innovative upstream bioprocessing technologies that facilitate in the elimination of biohazardous by-products using simplified procedures, are acting as growth-inducing factors. Biotechnological institutes and research organizations are also using novel high-performance gas and supercritical fluid chromatography, centrifugation and electrophoresis equipment for the separation of sensitive and large molecules. Other factors, including improvements in the healthcare infrastructure, especially in the developing economies, along with extensive research and development (R&D) in the field of biotechnology, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global separation systems for commercial biotechnology market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on methods and application.
Breakup by Methods:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Hitachi Ltd., Merck KGaA, Pall Corporation (Danaher Corporation), PerkinElmer Inc., Qiagen N.V, Repligen Corporation, Sartorius AG, Shimadzu Corporation and Thermo Fisher Scientific.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Methods, Application, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Agilent Technologies Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Hitachi Ltd., Merck KGaA, Pall Corporation (Danaher Corporation), PerkinElmer Inc., Qiagen N.V, Repligen Corporation, Sartorius AG, Shimadzu Corporation, Thermo Fisher Scientific. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global separation systems for commercial biotechnology market was valued at USD 28.2 Billion in 2024.
We expect the global separation systems for commercial biotechnology market to exhibit a CAGR of 4.98% during 2025-2033.
The rising demand for separation systems for commercial biotechnology across numerous industries, such as pharmaceutical, cosmetic, food and beverage, etc., as they offer improved resin productivity, higher recovery, and minimal waste generation and wash water usage, is primarily driving the global separation systems for commercial biotechnology market.
The sudden outbreak of the COVID-19 pandemic has led to the growing deployment of separation systems for commercial biotechnology for developing biopharmaceuticals, such as vaccines, to combat the spread of the coronavirus infection.
Based on the methods, the global separation systems for commercial biotechnology market has been segregated into modern methods and conventional methods, where conventional methods currently exhibit a clear dominance in the market.
Based on the application, the global separation systems for commercial biotechnology market can be bifurcated into pharmaceutical, food and cosmetics, agriculture, and others. Currently, the pharmaceutical industry holds the largest market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global separation systems for commercial biotechnology market include Agilent Technologies Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Hitachi Ltd., Merck KGaA, Pall Corporation (Danaher Corporation), PerkinElmer Inc., Qiagen N.V, Repligen Corporation, Sartorius AG, Shimadzu Corporation, and Thermo Fisher Scientific.